SSTR2 and neoplasm: Unfortunately, recently published data on tumor pharmacokinetics of the albumin-binding [67Cu]Cu‐DOTA-EB‐TATE in BON1-SSTR2+ and QGP‐1‐SSTR2+ xenograft mice lack a head-to-head comparison with the reference ligand [67Cu]Cu‐DOTA‐TATE50.